肝细胞白三烯B4受体1促进肥胖中非酒精性脂肪性肝病的发展
该研究探讨肝细胞白三烯B4受体1(Ltb4r1)在非酒精性脂肪性肝病(NAFLD)中的作用。肝细胞特异性敲除Ltb4r1可改善饮食诱导和遗传诱导肥胖小鼠的肝脏脂肪变性和全身胰岛素抵抗,机制涉及cAMP-PKA-IRE1α-XBP1s轴促进脂肪生成基因表达。抑制Ltb4r1可减轻肥胖小鼠脂肪肝表型,提示Ltb4r1是NAFLD的潜在治疗靶点。
要点
- 肝细胞特异性敲除Ltb4r1改善饮食诱导和遗传诱导肥胖小鼠的肝脏脂肪变性和全身胰岛素抵抗。
- LTB4/Ltb4r1通过激活cAMP-PKA-IRE1α-XBP1s轴直接促进肝细胞脂肪生成基因表达。
- 通过Ltb4r1抑制剂或慢病毒短发夹RNA抑制Ltb4r1可减轻肥胖小鼠脂肪肝表型。
核心结论
- LTB4/Ltb4r1通过激活PKA-IRE1α-XBP1s直接促进肝细胞脂肪生成,抑制肝细胞Ltb4r1可改善肝脏脂肪变性和胰岛素抵抗,Ltb4r1是NAFLD的潜在治疗靶点。
研究设计与样本
- 研究采用肝细胞特异性Ltb4r1敲除小鼠(饮食诱导和遗传诱导肥胖模型)、HepG2细胞和原代肝细胞,以及Ltb4r1抑制剂或慢病毒短发夹RNA递送抑制Ltb4r1的肥胖小鼠。
主要发现
- 肝细胞特异性敲除Ltb4r1改善饮食诱导和遗传诱导肥胖小鼠的肝脏脂肪变性和全身胰岛素抵抗。
- Ltb4r1敲除肥胖小鼠中参与从头脂肪生成和脂肪酸酯化的关键酶mRNA水平降低。
- LTB4/Ltb4r1直接促进HepG2细胞和原代肝细胞的脂肪生成。
- LTB4/Ltb4r1通过激活cAMP-PKA-IRE1α-XBP1s轴促进脂肪生成基因表达。
- 通过Ltb4r1抑制剂或慢病毒短发夹RNA抑制Ltb4r1减轻肥胖小鼠脂肪肝表型。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: NAFLD is the most prevalent chronic liver disease worldwide and has emerged as a serious public health issue with no approved treatment. The development of NAFLD is strongly associated with hepatic lipid content, and patients with NAFLD have significantly higher rates of hepatic de novo lipogenesis (DNL) than lean individuals. Leukotriene B4 (LTB4), a metabolite of arachidonic acid, is dramatically increased in obesity and plays important role in proinflammatory cytokine production and insulin resistance. But the role of liver LTB4/LTB4 receptor 1 (Ltb4r1) in lipid metabolism is unclear. APPROACH AND RESULTS: Hepatocyte-specific knockout (HKO) of Ltb4r1 improved hepatic steatosis and systemic insulin resistance in both diet-induced and genetically induced obese mice. The mRNA level of key enzymes involved in DNL and fatty acid esterification decreased in Ltb4r1 HKO obese mice. LTB4/Ltb4r1 directly promoted lipogenesis in HepG2 cells and primary hepatocytes. Mechanically, LTB4/Ltb4r1 promoted lipogenesis by activating the cAMP-protein kinase A (PKA)-inositol-requiring enzyme 1α (IRE1α)-spliced X-box-binding protein 1 (XBP1s) axis in hepatocytes, which in turn promoted the expression of lipogenesis genes regulated by XBP1s. In addition, Ltb4r1 suppression through the Ltb4r1 inhibitor or lentivirus-short hairpin RNA delivery alleviated the fatty liver phenotype in obese mice. CONCLUSIONS: LTB4/Ltb4r1 promotes hepatocyte lipogenesis directly by activating PKA-IRE1α-XBP1s to promote lipogenic gene expression. Inhibition of hepatocyte Ltb4r1 improved hepatic steatosis and insulin resistance. Ltb4r1 is a potential therapeutic target for NAFLD.
引用
- Liu X, Wang K, Wang L, et al. Hepatocyte leukotriene B4 receptor 1 promotes NAFLD development in obesity. Hepatology. 2022. PMID: 35931467. doi:10.1002/hep.32708
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。